The Risk of Major Bleeding With Apixaban Administration in Patients With Acute Kidney Injury.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 795, doi. 10.1177/10600280221129831
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 7
Results: 13
1
2
"N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review".
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 847, doi. 10.1177/10600280221138092
- By:
- Publication type:
- Article
3
Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 776, doi. 10.1177/10600280221133577
- By:
- Publication type:
- Article
4
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 769, doi. 10.1177/10600280221133376
- By:
- Publication type:
- Article
5
Risk Factors for Prolonged Opioid Use Following Total Hip Arthroplasty and Total Knee Arthroplasty: A Narrative Review of Recent Literature.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 837, doi. 10.1177/10600280221133078
- By:
- Publication type:
- Article
6
Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 762, doi. 10.1177/10600280221132851
- By:
- Publication type:
- Article
7
A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 867, doi. 10.1177/10600280221134719
- By:
- Publication type:
- Article
8
A Systematic Review of Antimicrobial Stewardship Interventions to Improve Management of Bacteriuria in Hospitalized Adults.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 855, doi. 10.1177/10600280221134539
- By:
- Publication type:
- Article
9
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 822, doi. 10.1177/10600280221134127
- By:
- Publication type:
- Article
10
A Meta-Analysis on the Impact of Prenatal and Early Childhood Antimicrobial Use on Autism Spectrum Disorders.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 813, doi. 10.1177/10600280221130280
- By:
- Publication type:
- Article
11
Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 803, doi. 10.1177/10600280221132019
- By:
- Publication type:
- Article
12
Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 787, doi. 10.1177/10600280221129348
- By:
- Publication type:
- Article
13
The Potential Synergistic Risk of Albuterol and Vasoactives in Acute Lung Injury Trials.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 7, p. 757, doi. 10.1177/10600280221128014
- By:
- Publication type:
- Article